Latest Drospirenone Stories

Ennis & Ennis, P.A. explains the findings of another recent study revealing the significant risk of developing dangerous blood blots associated with birth control pills such as Yaz and Yasmin. (PRWEB) November 09, 2011 The Canadian Medical Association Journal released a study of 330,000 Israeli women indicating that blood clots were more likely for those who were taking Yaz and Yasmin, which are birth control pills that contain the synthetic hormone drospirenone, reported attorney...

(Ivanhoe Newswire) – Drospirenone-containing oral birth control pills are linked to a significantly higher risk of blood clots, both deep vein thrombosis and pulmonary embolism, according to this study. All oral contraceptives are associated with a higher risk of blood clots, but there is conflicting information about the risk of adverse events with drospirenone. Many previous studies have evaluated risks of second- and third-generation contraceptives, which both contain derivatives of...

The use of drospirenone-containing oral birth control pills is linked to a significantly higher risk of blood clots, both deep vein thrombosis and pulmonary embolism, according to an article in the Canadian Medical Association Journal. All oral contraceptives are associated with a higher risk of blood clots, but there is conflicting information about the risk of adverse events with drospirenone. Many previous studies have evaluated risks of second- and third-generation contraceptives,...

Women Who Take Certain Oral Contraceptive Pills such as Yaz or Yasmin Are More Likely to Develop Venous Thromboembolism, Explains Ennis & Ennis, P.A. (PRWEB) October 28, 2011 A study published on October 25, 2011 by The British Medical Journal confirms previous findings that certain oral contraceptives containing newer types of progestogen hormones (drospirenone, desogestrel or gestodene), which are found in Yaz or Yasmin, at least double the risk of developing venous thromboembolism...

The Consumer Justice Foundation, a team of consumer advocate professionals who provide online resources for consumers that relay information regarding dealing with insurance companies and the dangers of pharmaceutical medications and whose URL can be found at http://www.SideEffectsRX.com, hereby alerts the public of a joint meeting held by the FDA including the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee on December 8, 2011 to...

Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9 A study published on http://www.bmj.com today confirms previous findings that certain oral contraceptive pills are more likely to cause serious blood clots (venous thromboembolism - VTE ) than others. The authors, led by Dr Øjvind Lidegaard from the University of Copenhagen, say that women on pills containing one of the newer types of...

PHILADELPHIA, Sept. 27, 2011 /PRNewswire-USNewswire/ -- On Monday, the United States Food and Drug Administration ("FDA") said its primary results of an agency funded study suggest a 1.5 fold increase risk of blood clots for women who use drospirenone-containing birth control products, such as Yaz and Yasmin. The safety of Yaz and Yasmin is the subject of approximately 2,000 lawsuits filed in Pennsylvania before Philadelphia Court of Common Pleas Judge Sandra Mazer Moss, Coordinating Judge...

NEW YORK, Aug. 23, 2011 /PRNewswire/ -- Wendy R. Fleishman of the national plaintiffs' law firm Lieff Cabraser Heimann & Bernstein, LLP announced that Tiffany Littles, 33, of Jacksonville, Florida, filed a personal injury lawsuit against Bayer Healthcare Pharmaceuticals, Inc., for severe and lasting injuries caused by Bayer's birth control drug Yaz. Littles' complaint charges that Yaz is a dangerous prescription drug sold without adequate warnings about the risk of serious injuries....

The US Drug Watchdog is calling its Yaz, Yasmin, or the generic version of these birth control pills called Ocella, their most important women's health care initiative ever. The group says, "If a user of the birth control pills called Yaz, Yasmin, or the generic version Ocella has had a pulmonary embolism, a heart attack, stroke, blood clotting, or other severe medical complications, while taking these birth control pills, we want to know about it. We are hearing horror stories...

The US Drug Watchdog says, "We are horrified with the stories we are getting from women from the United States, Canada, Australia, related to the birth control pills called Yaz, Yasmin, or the generic version Ocella. We are talking about heart attacks, strokes, pulmonary embolisms, and we fear death. These are not old women. In most instances we are talking about women in their early twenties. Even more worrisome, in some cases the young women we are talking about are extremely athletic,...